Related Experiment Video
Updated: Aug 8, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Respiratory abnormalities in infants of substance-abusing mothers: role of prematurity
P L Toubas1, K C Sekar, E Wyatt
1Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City 73190.
Insights
Maternal drug exposure during pregnancy did not significantly increase apnea in newborns. Premature infants showed more apnea, but this was linked to gestational age, not drug exposure.
Area of Science:
- Neonatology
- Pharmacology
- Respiratory Physiology
Background:
- Maternal drug addiction during pregnancy is hypothesized to increase newborn apnea.
- Neonatal drug exposure may impact respiratory patterns and oxygenation.
Purpose of the Study:
- To investigate the association between in utero exposure to cocaine and other drugs and the incidence of apnea in newborns.
- To compare respiratory parameters between drug-exposed and non-exposed term and preterm infants.
Main Methods:
- Polygraphic studies of respiration were conducted on term and preterm infants.
- Variables included heart rate, respiration, chest impedance pneumography, nasal airflow, and oxygen saturation (pulse oximetry).
- Apnea indices (central, obstructive, short/long duration) and periodic breathing were analyzed.
Main Results:
- Term drug-exposed infants showed less central apnea and more periodic breathing than controls; differences were clinically insignificant.
- Premature drug-exposed infants exhibited more obstructive apnea and less periodic breathing than controls; differences were clinically insignificant.
- Premature infants, regardless of drug exposure, had significantly higher rates of central apnea, obstructive apnea, and periodic breathing, attributed to gestational age.
Conclusions:
- In utero exposure to cocaine and other drugs did not demonstrate a significant inhibition of respiration in newborns.
- Gestational age, rather than drug exposure, was the primary determinant of respiratory differences observed between term and preterm infants.
- The study found no clinically significant evidence linking maternal drug addiction and neonatal drug detection to increased apnea incidence.
Abstract:
It is a current hypothesis that maternal history of drug addiction during pregnancy and detection of drugs in the urine of the newborn are associated with increased incidence of apnea. To test this hypothesis, we reviewed polygraphic studies of respiration in two groups of infants who had been exposed in utero to cocaine (and other drugs). The first group was composed of 20 term infants (39.1 +/- 0.8 weeks gestation), and premature infants (35.4 +/- 0.8 weeks gestation). None of the infants were on methylxanthines. These infants were matched with 15 term and 15 preterm infants of similar gestational age. Variables studied were: heart rate, respiration, chest impedance pneumography, nasal airflow and oxygen saturation (pulse oximetry). Apnea indices for central and obstructive events of short and long duration as well as periodic breathing and oxygen saturation were obtained. Term drug-exposed infants had less central apnea and a higher rate of periodic breathing compared to term controls, whereas drug-exposed premature infants had more obstructive apnea and less periodic breathing compared to premature controls. These observed differences within groups were subtle and clinically insignificant. Other parameters studied were not different. When term and preterm infants were compared, preterm infants had significantly higher central apnea, obstructive apnea and periodic breathing rates. These differences appeared to be related to gestational age differences, not to drug exposure. There was no evidence that exposure to cocaine and other drugs actually inhibited respiration.
More Related Videos
07:36Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
06:15Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Related Concept Videos
Breathing
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Pulmonary Cycle: Exhalation
Respiratory System Abnormal Finding I: Inspection and Percussion
Inspection Findings
During an inspection, several findings may suggest the presence of respiratory distress or disease. Pursed-lip breathing, where exhalation is slowed by...
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-III